NCT00761501View on ClinicalTrials.gov

Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy Volunteer
Interventions
DRUG

PN400

Oral

DRUG

Naproxen (Proxen S)

Oral

DRUG

Naproxen (Naprosyn E)

Oral

Trial Locations (2)

Unknown

Research Site, Luleå

Research Site, Uppsala

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY